Penumbra, Inc. (PEN) is listed on NYSE in Medical Device Stocks. It is $321.58, +0.18%, with a $12.7B market cap. RSI is 47.0, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 47.0 Neutral
Market Cap $12.7B
Volume 89.9K
Fundamentals — 10-Q Q2 2026
Revenue $764.8M
Net Income $67.4M
EPS $1.70
Gross Margin 67.8%
Operating Margin 10.4%
Net Margin 8.8%
P/E Ratio 189.2x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Grewal Harpreet | Director | Sell | 100 | $328.22 | $32,822 | 2026 Apr 2 |
| Yuen Maggie | Chief Financial Officer | Sell | 2,432 | $342.30 | $832,474 | 2026 Mar 2 |
| Bose Arani | Director | Sell | 15,000 | $308.82 | $4.6M | 2025 Dec 11 |
| Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 300 | $300.13 | $90,039 | 2025 Dec 5 |
| Grewal Harpreet | Director | Sell | 100 | $292.98 | $29,298 | 2025 Dec 2 |
| Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $294.94 | $176,966 | 2025 Dec 1 |
| Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 1,800 | $300.06 | $540,108 | 2025 Nov 25 |
| Bose Arani | Director | Sell | 7,500 | $300.19 | $2.3M | 2025 Nov 25 |
| Bose Arani | Director | Sell | 7,500 | $290.56 | $2.2M | 2025 Nov 21 |
| Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $266.98 | $160,189 | 2025 Nov 10 |
| Grewal Harpreet | Director | Sell | 186 | $227.58 | $42,330 | 2025 Nov 4 |
| Grewal Harpreet | Director | Sell | 186 | $248.61 | $46,241 | 2025 Oct 2 |
| Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $249.70 | $149,820 | 2025 Oct 1 |
| Wilder Thomas | Director | Sell | 186 | $253.93 | $47,231 | 2025 Oct 1 |
| Elsesser Adam | CEO | Sell | 15,800 | $269.65 | $4.3M | 2025 Sep 3 |
| Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $270.58 | $162,347 | 2025 Sep 2 |
| Grewal Harpreet | Director | Sell | 186 | $272.19 | $50,627 | 2025 Sep 2 |
| Elsesser Adam | CEO and President | Sell | 15,900 | $254.53 | $4.0M | 2025 Aug 20 |
| Bose Arani | Director | Sell | 12,000 | $250.65 | $3.0M | 2025 Aug 13 |
| Yuen Maggie | Chief Financial Officer | Sell | 2,000 | $250.00 | $500,000 | 2025 Aug 13 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $100.92 | 61.9 | $19.2B |
| | $157.56 | 36.9 | $11.2B |
| | $100.74 | 44.7 | $6.6B |
| | $233.75 | 57.8 | $22.8B |
Take PEN further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put PEN in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Penumbra, Inc. next reports.
Set alerts on PEN
Get notified when Penumbra, Inc. hits your price targets or technical conditions are met.
Get Started Free